Press releases 23 Apr 2024 Promising patient-friendly oral drug against visceral leishmaniasis enters Phase II clinical trial in Ethiopia
In the media 14 Apr 2024 La pionera en la lucha contra las enfermedades desatendidas que anima a las niñas a seguir su ejemplo: ‘Vuestros sueños son válidos’ El Pais
In the media 11 Apr 2024 La pionera en la lucha contra las enfermedades desatendidas que anima a las niñas a seguir su ejemplo: ‘Vuestros sueños son válidos’ El Pais
In the media 9 Apr 2024 L’accès très inégal aux traitements contre les hépatites B et C, qui ont causé 1,3 million de morts en 2022 Le Monde
Press releases 3 Apr 2024 DNDi signs memorandum of understanding with Kenya Medical Research Institute
Scientific articles 2 Apr 2024 AI is a viable alternative to high throughput screening: a 318-target study Nature Scientific Reports
Scientific articles 29 Mar 2024 Practical Synthesis of 6-Amino-1-hydroxy-2,1-benzoxaborolane: A Key Intermediate of DNDI-6148 Organic Process Research & Development
Scientific articles 2 Apr 2024 AI is a viable alternative to high throughput screening: a 318-target study Nature Scientific Reports
Scientific articles 29 Mar 2024 Practical Synthesis of 6-Amino-1-hydroxy-2,1-benzoxaborolane: A Key Intermediate of DNDI-6148 Organic Process Research & Development
Scientific articles 26 Mar 2024 Towards enhanced control of mycetoma: a roadmap to achieve the UN’s sustainable development goals by 2030 Transactions of The Royal Society of Tropical Medicine and Hygiene
Scientific articles 26 Mar 2024 High-throughput screening of small-molecules libraries identified antibacterials against clinically relevant multidrug-resistant A. baumannii and K. pneumoniae eBioMedicine
Scientific articles 15 Mar 2024 Bioavailability of three novel oral, sustained-release pellets, relative to an immediate-release tablet containing 500 mg flucytosine: A randomized, open-label, crossover study in healthy volunteers Clinical and Translational Science
Scientific articles 21 Feb 2024 Involving patients in drug development for Neglected Tropical Diseases (NTDs): A qualitative study exploring and incorporating preferences of patients with cutaneous leishmaniasis into Target Product Profile development PLOS Neglected Tropical Diseases
Scientific articles 20 Feb 2024 A sample-centric and knowledge-driven computational framework for natural products drug discovery ASCS Central Science
Scientific articles 24 Jan 2024 Generation and evaluation of protease inhibitor-resistant SARS-CoV-2 strains Antiviral Research
Scientific articles 23 Jan 2024 Bioluminescence imaging reveals enhanced SARS-CoV-2 clearance in mice with combinatorial regimens iScience
Scientific articles 21 Jan 2024 Population pharmacokinetics of pediatric lopinavir/ritonavir oral pellets in children living with HIV in Africa Clinical Pharmacology and Therapeutics
Scientific articles 10 Jan 2024 Efficacy and safety of fexinidazole for treatment of chronic indeterminate Chagas disease (FEXI-12): a multicentre, randomised, double-blind, phase 2 trial The Lancet Infectious Diseases
Scientific articles 25 Dec 2023 Madurastatins with imidazolidinone rings: Natural products or side-reaction products from extraction solvents? International Journal of Molecular Sciences
Scientific articles 15 Dec 2023 Facing the escalating burden of dengue: Challenges and perspectives PLOS Global Public Health
Scientific articles 13 Dec 2023 Short-course combination treatment for experimental chronic Chagas disease Science Translational Medicine
Scientific articles 13 Dec 2023 DNDI-6174 is a preclinical candidate for visceral leishmaniasis that targets the cytochrome bc1 Science Translational Medicine
Scientific articles 5 Dec 2023 Estimating the proportion of relapse following treatment of visceral leishmaniasis: meta-analysis using Infectious Diseases Data Observatory (IDDO) systematic review Lancet Regional Health Southeast Asia